Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A2 activity in atherosclerotic plaque-Reference-Cited by-同舟云学术

Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A2 activity in atherosclerotic plaque

Published:2017-12 Issue: Volume:267 Page:78-89
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Otsuka Fumiyuki,Zhao XiaoQing,Trout Hugh H.,Qiao Ye,Wasserman Bruce A.,Nakano Masataka,Macphee Colin H.,Brandt Martin,Krug-Gourley Sue,Guo Liang,Ladich Elena R.,Cheng Qi,Davis Harry R.,Finn Aloke V.,Virmani Renu,Kolodgie Frank D.

Funder

Uehara Memorial Foundation

GlaxoSmithKline

CVPath Institute

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference47 articles.

1. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group;Packard;N. Engl. J. Med.,2000

2. Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors: the Ludwigshafen Risk and Cardiovascular Health Study;Winkler;Circulation,2005

3. Lipoprotein-associated phospholipase A(2) and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies;Thompson;Lancet,2010